Dr. Lawrence Martin Flechner, MD, PhD

Dr. Flechner practices at Genesis Healthcare Partners in Torrance, California.

Dr. Flechner's NPI, 1689815458, was assigned on March 9, 2009. Dr. Flechner graduated from UC San Diego School of Medicine in 2006. Dr. Flechner's California license number on file is A103673.

Dr. Flechner's primary practice is Genesis Healthcare Partners, at 23600 Telo Ave, Torrance, CA 90505 in Los Angeles County. The practice phone is (760) 436-4558.

Dr. Flechner's primary practice is Genesis Healthcare Partners in Torrance, California. Dr. Flechner is also affiliated with Torrance Memorial Medical Center. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Flechner to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Flechner practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Flechner's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Flechner is board certified in urology by the American Board of Urology. Dr. Flechner has a license on file in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and kidney stones among the conditions Dr. Flechner treats.

CMS data shows 7,970 Medicare services from Dr. Flechner across 26 procedure codes in 2024, for 1,046 Medicare patients. Medicare paid $414,307 for them.

CMS counts 1,046 Medicare patients who saw Dr. Flechner in 2024. The largest group is 75 to 84, with 444 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Flechner's median patient age at 73, with 15% women.

In 2024, Dr. Flechner wrote 3,485 Medicare Part D claims for 854 patients. 89% of them were for generic drugs. CMS names the drug for 3,350 of them, across 29 drugs with 11 or more claims each, at $2,037,760 in total drug cost. In 2023, CMS named 3,079 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Flechner for performance year 2024, reported as part of a group. Dr. Flechner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Flechner as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Flechner, published from 2004 to 2012. 2012 was the busiest year, with 2. The most frequent topics are Cell Line, Cyclic AMP Response Element-Binding Protein and Phosphorylation. Dr. Flechner has published most often in J Urol. Dr. Flechner's most frequent co-authors are Sarah Dawn Blaschko, MD, James F. Smith, MD and Marshall L. Stoller, MD.

CMS Open Payments shows 968 general payments to Dr. Flechner from 76 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $7,647.

Dmand AI lists 1 award for Dr. Flechner.

Dr. Flechner graduated from UC San Diego School of Medicine in 2006. Dr. Flechner is a member of ACS.

Dr. Flechner is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.